Therefore, both CD56+ and CD56− IL-15 DC fractions were co-cultured with the K562 tumor cell line and examined for lytic activity using a PI/Annexin-V-based flow cytometric lysis assay. The gene discussed is ANXA5; the disease is neoplasm.